Palatin Technologies
PTN
#10386
Rank
ยฃ16.47 M
Marketcap
ยฃ9.26
Share price
3.20%
Change (1 day)
13,700.66%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -ยฃ3.81 Million

According to Palatin Technologies's latest financial reports the company's current earnings are ยฃ8.84 Million. In 2024 the company made an earning of -ยฃ20.36 Million, an increase over its 2023 earnings that were of -ยฃ24.5 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ3.81 Million-81.3%
2024 -ยฃ20.36 Million-16.9%
2023 -ยฃ24.5 Million5.99%
2022 -ยฃ23.12 Million-13.7%
2021 -ยฃ26.79 Million33.25%
2020 -ยฃ20.1 Million-172.11%
2019 ยฃ27.87 M2352.33%
2018 ยฃ1.13 M-94.13%
2017 ยฃ19.36 M-154.92%
2016 -ยฃ35.27 Million3.67%
2015 -ยฃ34.02 Million878%
2014 -ยฃ3.48 Million-72.64%
2013 -ยฃ12.72 Million-33.11%
2012 -ยฃ19.01 Million77.71%
2011 -ยฃ10.7 Million
2003 -ยฃ18.11 Million29.93%
2002 -ยฃ13.94 Million36.18%
2001 -ยฃ10.24 Million
1999 -ยฃ8.5 Million6.04%
1998 -ยฃ8.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.63 B-541,884.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ11.08 B-305,913.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ0.60 B-16,758.74%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-ยฃ9.08 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.12 B-3,513.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ88.92 Million 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ72.39 M-2,097.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-ยฃ22.29 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-ยฃ43.79 Million 1,108.36%๐Ÿ‡บ๐Ÿ‡ธ USA